Results 41 to 50 of about 4,083,428 (217)
From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice. [PDF]
Kim J, Lochhead L, Weissman CR.
europepmc +2 more sources
Mindfulness-based interventions and psychedelic-assisted therapy have been experimentally utilised in recent years as alternative treatments for various psychopathologies with moderate to great success.
Maria Eleni Eleftheriou, Emily Thomas
doaj +1 more source
Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology [PDF]
Psychedelic-assisted psychotherapy is being investigated as a treatment for a range of psychiatric illnesses. Current research suggests that the kinds of subjective experiences induced by psychedelic compounds play key roles in producing therapeutic ...
Miceli McMillan, Riccardo +3 more
core +1 more source
Group psychedelic therapy: empirical estimates of cost-savings and improved access
ObjectiveTo compare group and individual psychedelic-assisted therapy in terms of clinician time, costs and patient access.MethodsUsing 2023 data from two group therapy trial sites, one using 3,4-Methylenedioxymethamphetamine (MDMA) to treat ...
Elliot Marseille +7 more
doaj +1 more source
The economics of psychedelic-assisted therapies: A research agenda
After a long hiatus, psychiatry is undergoing a resurgence of interest in psychedelic drugs as therapy for a wide range of mental health disorders Accumulating clinical evidence suggests substantial potential for psychedelics used in a therapeutic context, as treatment for, among other disorders, depression, post-traumatic stress disorder (PTSD), and ...
Elliot Marseille +7 more
openaire +5 more sources
Psychedelic-Assisted Psychotherapy: When Two Traditions Meet
Introduction After a long moratorium since the Controlled Substances Act was passed in 1970, there has been a resurgence of research on the potential therapeutic benefits of psychedelic (PE) compounds. It has been widely believed that the PE effect is a
E. Frecska, A. Kazai, P. Bokor
doaj +1 more source
IntroductionPsychedelic-assisted therapy with psilocybin has shown promise in Phase 2 trials for alcohol use disorder (AUD). Set and setting, particularly factors facilitating a connection with nature, may positively influence the psychedelic experience ...
Keith G. Heinzerling +11 more
doaj +1 more source
Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice
Psychedelic Harm Reduction and Integration (PHRI) is a transtheoretical and transdiagnostic clinical approach to working with patients who are using or considering using psychedelics in any context.
Ingmar Gorman +11 more
doaj +1 more source
Psychedelic-assisted therapy research for depression and PTSD has been fast tracked in the United States with the Food and Drugs Administration (FDA) granting breakthrough designations for MDMA (post-traumatic stress disorder) and psilocybin (major ...
Henry J. Whitfield (11803265)
core +1 more source
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
The efficacy of psychedelic-assisted therapies for mental disorders has been attributed to the lasting change from experiential avoidance to acceptance that these treatments appear to facilitate.
Max Wolff +8 more
doaj +1 more source

